规范与实施方案

新型冠状病毒感染相关心肌炎诊断和治疗建议

展开
  • 上海交通大学医学院附属瑞金医院心脏中心,上海 200025

收稿日期: 2023-01-02

  网络出版日期: 2023-02-13

Recommendations on diagnosis and treatment of myocarditis associated with novel coronavirus infection

Expand

Received date: 2023-01-02

  Online published: 2023-02-13

本文引用格式

金玮, 杨晨蝶, 王玲洁, 张凤如, 赵强, 吴立群, 张瑞岩 . 新型冠状病毒感染相关心肌炎诊断和治疗建议[J]. 内科理论与实践, 2023 , 18(01) : 5 -9 . DOI: 10.16138/j.1673-6087.2023.01.002

参考文献

[1] Gluckman TJ, Bhave NM, Allen LA, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play[J]. J Am Coll Cardiol, 2022, 79(17): 1717-1756.
[2] Singer ME, Taub IB, Kaelber DC. Risk of myocarditis from COVID-19 infection in people under age 20[J/OL]. MedRxiv, 2022. https://www.medrxiv.org/content/10.1101/2021.07.23.21260998v2.
[3] Ammirati E, Lupi L, Palazzini M, et al. Prevalence, cha-racteristics, and outcomes of COVID-19-associated acute myocarditis[J]. Circulation, 2022, 145(15): 1123-1139.
[4] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506.
[5] Lala A, Johnson KW, Russak AJ, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection[J]. J Am Coll Cardiol, 2020, 76(5): 533-546.
[6] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, 323(11): 1061-1069.
[7] Rathore SS, Rojas GA, Sondhi M, et al. Myocarditis associated with Covid-19 disease: a systematic review of published case reports and case series[J]. Int J Clin Pract, 2021, 75(11): e14470.
[8] Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries[J]. PLoS One, 2020, 15(6): e0234765.
[9] Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID[J]. Nat Med, 2021, 27(4): 626-631.
[10] 中华医学会心血管病学分会精准医学学组, 中华心血管病杂志编辑委员会, 成人暴发性心肌炎工作组. 成人暴发性心肌炎诊断与治疗中国专家共识[J]. 中华心血管病杂志, 2017, 45(9): 742-752.
[11] Fayol A, Livrozet M, Boutouyrie P, et al. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study[J]. ESC Heart Fail, 2021, 8(3): 2232-2239.
[12] 国家老年医学中心/国家老年疾病临床医学研究中心, 中国老年医学学会心血管病分会, 北京医学会心血管病学会影像学组. 新型冠状病毒肺炎相关心肌损伤的临床管理专家建议(第一版)[J]. 中国循环杂志, 2020, 35(4): 326-330.
[13] Kelle S, Bucciarelli-Ducci C, Judd RM, et al. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection[J]. J Cardiovasc Magn Reson, 2020, 22(1): 61.
[14] Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis[J]. Eur Heart J, 2013, 34(33): 2636-2648.
[15] Seferoviéc PM, Tsutsui H, Mcnamara DM, et al. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society position statement on endomyocardial biopsy[J]. J Card Fail, 2021, 27(7): 727-743.
[16] Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology[J]. J Am Coll Cardiol, 2007, 50(19): 1914-1931.
[17] 国务院联防联控机制综合组. 关于印发新型冠状病毒感染防控方案(第十版)的通知[EB/OL]. 2023. http://www.gov.cn/xinwen/202301/07/content_5735448.htm.
[18] Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2022, 79(17): e263-e421.
文章导航

/